Pulmonary drug delivery strategies: A concise, systematic review

被引:183
作者
Patil, J. S. [1 ]
Sarasija, S. [2 ]
机构
[1] BLDE Univ Campus, BLDEAs Coll Pharm, Dept Pharmaceut, Bijapur, India
[2] Al Ameen Coll Pharm, Dept Pharmaceut, Bangalore, Karnataka, India
关键词
Dry powder inhaler; lung deposition; pulmonary route; targeted drug delivery;
D O I
10.4103/0970-2113.92361
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Because of limitations associated with the conventional treatment of various chronic diseases a growing attention has been given to the development of targeted drug delivery systems. Pulmonary route of drug delivery gaining much importance in the present day research field as it enables to target the drug delivery directly to lung both for local and systemic treatment. Over the last 2 decades, the systemic absorption of a broad range of therapeutics after pulmonary application has been demonstrated in animals as well as in humans. This review was prepared with an aim to discuss the technical, physiological, and efficacy aspects of the novel pulmonary route of drug targeting. The review also focuses on the mechanisms of pulmonary drug administration along with compatibility of the excipients employed, devices used, and techniques of particulate dosage production. This review was prepared based on the method of extensive literature survey on the topics covering all the aspects discussed in the present subject. Hence, the better understanding of complexes and challenges facing the development of pulmonary drug delivery system offer an opportunity to the pharmaceutical scientist in minimizing the clinical and technical gaps.
引用
收藏
页码:44 / 49
页数:6
相关论文
共 49 条
[41]   Optimisation of powders for pulmonary delivery using supercritical fluid technology [J].
Rehman, M ;
Shekunov, BY ;
York, P ;
Lechuga-Ballesteros, D ;
Miller, DP ;
Tan, T ;
Colthorpe, P .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 22 (01) :1-17
[42]   Solution-based particle formation of pharmaceutical powders by supercritical or compressed fluid CO2 and cryogenic spray-freezing technologies [J].
Rogers, TL ;
Johnston, KP ;
Williams, RO .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2001, 27 (10) :1003-1015
[43]   Aerosolized protein delivery in asthma: Gamma camera analysis of regional deposition and perfusion [J].
Sangwan, S ;
Agosti, JM ;
Bauer, LA ;
Otulana, BA ;
Morishige, RJ ;
Cipolla, DC ;
Blanchard, JD ;
Smaldone, GC .
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 2001, 14 (02) :185-195
[44]  
Scheuch G, 2007, J PHYSIOL PHARMACOL, V58, P615
[45]  
Siekmeier R, 2008, PHYSL PHARM, V59, P53
[46]   Deagglomeration of dry powder pharmaceutical aerosols [J].
Voss, A ;
Finlay, WH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 248 (1-2) :39-50
[47]  
White Steven, 2005, Diabetes Technol Ther, V7, P896, DOI 10.1089/dia.2005.7.896
[48]   Spray freezing into liquid nitrogen for highly stable protein nanostructured microparticles [J].
Yu, ZS ;
Garcia, AS ;
Johnston, KP ;
Williams, RO .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 58 (03) :529-537
[49]   Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis [J].
Zahoor, A ;
Sharma, S ;
Khuller, GK .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 26 (04) :298-303